MoreRelyvrio/Albrioza: New Drug for Amyotrophic Lateral Sclerosis Treatment • BioPharma MediaSep 29, 2022
MoreBeyfortus: Effective Protection for Infants Against Respiratory Syncytial Virus • BioPharma MediaSep 17, 2022
MorePfizer and Moderna Release Booster Vaccines to Protect Against Omicron • BioPharma MediaSep 1, 2022
MoreDoxycycline Protects Against Gonorrhea, Chlamydia, and Syphilis Infections • BioPharma MediaAug 4, 2022
MoreQalsody: New Drug for Amyotrophic Lateral Sclerosis with SOD1 Mutation • BioPharma MediaAug 2, 2022
MoreEvusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus • BioPharma MediaJun 8, 2022
MoreTalicia: Highly Effective Eradication Regimen for Helicobacter pylori • BioPharma MediaJun 5, 2022
MoreVijoice: First Targeted Treatment for PIK3CA-Related Overgrowth Spectrum (PROS) • BioPharma MediaApr 23, 2022
MoreIgalmi: New Drug for Agitation in Schizophrenia and Bipolar Disorder • BioPharma MediaApr 7, 2022
MoreTwymeeg: Completely New Drug for Treatment of Type 2 Diabetes Mellitus • BioPharma MediaFeb 17, 2022
MoreVabysmo: New Drug for Wet Age-Related Macular Degeneration and Diabetic Macular Edema • BioPharma MediaFeb 1, 2022
MoreTecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma • BioPharma MediaJan 30, 2022
MoreKimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma • BioPharma MediaJan 27, 2022
MoreSusvimo: Pioneering Implant for Treating Wet Age-Related Macular Degeneration • BioPharma MediaJan 20, 2022
MoreBuntanetap: Breakthrough in Treatment of Alzheimer's and Parkinson's • BioPharma MediaJan 11, 2022
MoreOmicron Variant: Latest Scientific News, Findings, Evidence, and Developments • BioPharma MediaDec 17, 2021
MoreInnovative Treatment for Hypertension: One Shot Every Quarter or Even Six Months • BioPharma MediaDec 16, 2021
MoreFetroja/Fetcroja: New Cephalosporin That Bypasses All Antibiotic Resistance • BioPharma MediaDec 11, 2021